Acute Respiratory Distress Syndrome after Rituximab Infusion

Rituximab, a humanized monoclonal antibody approved for malignant lymphoma, is being increasingly, effectively, and safely used for immune thrombocytopenic purpura (ITP) and other humoral autoimmune disorders. We report the case of a 43-year-old man with ITP refractory to steroids and intravenous im...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero, Alberto J., McCarthy, John J., Chen, George, Rice, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2005
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101654/
https://www.ncbi.nlm.nih.gov/pubmed/16298824
http://dx.doi.org/10.1532/IJH97.NA0506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101654/
https://www.ncbi.nlm.nih.gov/pubmed/16298824
http://dx.doi.org/10.1532/IJH97.NA0506

Ejemplares similares